Recall of certain batches of NovoSeven® for Injection (eptacog alfa) 2.4mg vial to patient level

Novo Nordisk Pharma (S) Pte Ltd in consultation with the Health Sciences Authority is conducting a voluntary recall of NovoSeven® for Injection 2.4mg vial for the following batches YU61075, YU61478 and YU61368. The voluntary recall of NovoSeven® for Injection 2.4mg vial is a precautionary measure as some of the NovoSeven® for Injection 2.4mg vials from 3 batches were found to be cracked and therefore potentially exposing the product to microbial or other contamination. The batches were first distributed to local pharmacies and hospitals since 1 Feb 2011. Healthcare professionals are advised to quarantine existing stock from the 3 batches and contact any patients who have been supplied with these batches and ask them to return the product as soon as possible.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.